All News
No Seed Oil-Colon Cancer Link; Avoiding Prostate Biopsy; Top Cancer Advances
(MedPage Today) -- Seed oils (sunflower, sesame, etc.) are not driving the surge in colon cancer cases among younger people.
Read MoreSTAT+: What Novo Nordisk’s disappointing trial results mean for the obesity drug market
New clinical trial data from Novo Nordisk raise questions for the broad landscape of obesity drug development and the way investors view emerging candidates.
Read MoreI thought I was a bad listener. Turns out, I couldn’t hear
Conversations in crowded places were difficult and I didn’t like podcasts – then a hearing test changed everythingI thought I was just a bad listener.I didn’t like podcasts.
Read MoreWhat Can Be Done for Severe RSV Cases in Adults?
(MedPage Today) -- Though there are now respiratory syncytial virus (RSV) vaccines approved by the FDA and recommended by the CDC for certain high-risk adults, what happens when someone ends up with
Read MoreSticking With CDK4/6 Inhibitors for Breast Cancer Wins in Post-Progression Setting
(MedPage Today) -- Patients with advanced estrogen receptor (ER)-positive breast cancer that progressed on CDK4/6 inhibitors had better survival if they continued CDK4/6 inhibition plus endocrine the
Read MoreA Thin Shred of My Sanity Remained. Then I Hit My Breaking Point.
(MedPage Today) -- I distinctly remember one Tuesday morning during the second half of my first year of ophthalmology residency in 2014. It was 6 a.m.
Read MoreAsymptomatic Brain Metastases in EGFR-Mutant NSCLC
(MedPage Today) -- Brain metastases are a common problem in patients with EGFR-mutated non-small cell lung cancer (NSCLC), occurring in about one-fifth to one-quarter of patients.
Read MoreRandy Moss' Rare GI Cancer: Here's What to Know
(MedPage Today) -- Former NFL wide receiver Randy Moss announced last week that he underwent a 6-hour surgery for a rare and aggressive gastrointestinal cancer.
Read MoreQuads, Frailty, and the Future: Evolving Frontline Strategies in Multiple Myeloma
(MedPage Today) -- Using quadruplet regimens with anti-CD38 monoclonal antibodies, such as daratumumab (Darzalex) or isatuximab (Sarclisa), has significantly advanced frontline therapy for both trans
Read MoreNext-Generation Therapies for Multiple Myeloma
(MedPage Today) -- The treatment landscape for multiple myeloma is evolving rapidly, with novel therapies offering renewed hope for patients with relapsed or refractory disease.
Read More